Eileen Barry

Eileen Barry

UNVERIFIED PROFILE

Are you Eileen Barry?   Register this Author

Register author
Eileen Barry

Eileen Barry

Publications by authors named "Eileen Barry"

Are you Eileen Barry?   Register this Author

59Publications

984Reads

14Profile Views

Characterization of Schu S4 mutants as live attenuated tularemia vaccine candidates.

Virulence 2020 Dec;11(1):283-294

Center for Vaccine Development, University of Maryland Baltimore, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21505594.2020.1746557DOI Listing
December 2020

A roadmap for enterotoxigenic vaccine development based on volunteer challenge studies.

Hum Vaccin Immunother 2019 20;15(6):1357-1378. Epub 2019 Mar 20.

a Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/21645515.2019.1
Publisher Site
http://dx.doi.org/10.1080/21645515.2019.1578922DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663128PMC
March 2020

A tale of two bacterial enteropathogens and one multivalent vaccine.

Cell Microbiol 2019 Nov 10;21(11):e13067. Epub 2019 Jul 10.

School of Medicine, Center for Vaccine Development and Global Health, University of Maryland, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cmi.13067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842089PMC
November 2019

Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE Conference.

Vaccine 2019 Aug;37(34):4768-4774

PATH, 4555 Massachusetts Ave NW, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2019.02.070DOI Listing
August 2019

Evaluating Shigella flexneri Pathogenesis in the Human Enteroid Model.

Infect Immun 2019 04 25;87(4). Epub 2019 Mar 25.

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/IAI.00740-18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434113PMC
April 2019

Deletion of the Major Facilitator Superfamily Transporter Alters Host Cell Interactions and Attenuates Virulence of Type A Francisella tularensis.

Infect Immun 2018 03 20;86(3). Epub 2018 Feb 20.

Institute for Global Health, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/IAI.00832-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820938PMC
March 2018

Analysis of Shigella flexneri Resistance, Biofilm Formation, and Transcriptional Profile in Response to Bile Salts.

Infect Immun 2017 06 23;85(6). Epub 2017 May 23.

Mucosal Immunology and Biology Research Center, Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/IAI.01067-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442615PMC
June 2017

The synthesis of OspD3 (ShET2) in Shigella flexneri is independent of OspC1.

Gut Microbes 2016 11 22;7(6):486-502. Epub 2016 Sep 22.

a Department of Medicine, Center for Vaccine Development , University of Maryland School of Medicine , Baltimore , Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/19490976.2016.1239682DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103656PMC
November 2016

Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.

Pathog Dis 2016 07 21;74(5). Epub 2016 Apr 21.

Institute for Global Health, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/femspd/ftw034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985478PMC
July 2016

Simple method for purification of enterotoxigenic Escherichia coli fimbriae.

Protein Expr Purif 2016 Mar 12;119:130-5. Epub 2015 Nov 12.

Center for Vaccine Development, University of Maryland Medical School, Baltimore, MD, USA; Department of Medicine, University of Maryland Medical School, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pep.2015.11.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721563PMC
March 2016

Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates.

Pathog Dis 2015 Aug 17;73(6):ftv036. Epub 2015 May 17.

Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/femspd/ftv036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462183PMC
August 2015

Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans.

Front Immunol 2014 20;5:374. Epub 2014 Aug 20.

Center for Vaccine Development, University of Maryland School of Medicine , Baltimore, MD , USA ; Department of Microbiology and Immunology, University of Maryland School of Medicine , Baltimore, MD , USA ; Department of Pediatrics, University of Maryland School of Medicine , Baltimore, MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2014.00374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138503PMC
September 2014

Characterization of intracellular growth regulator icgR by utilizing transcriptomics to identify mediators of pathogenesis in Shigella flexneri.

Infect Immun 2013 Sep 10;81(9):3068-76. Epub 2013 Jun 10.

Department of Microbiology and Immunology, Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/IAI.00537-13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754207PMC
September 2013

Live attenuated tularemia vaccines: recent developments and future goals.

Vaccine 2013 Aug 10;31(35):3485-91. Epub 2013 Jun 10.

University of Maryland School of Medicine, Baltimore, MD, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2013.05.096DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766925PMC
August 2013

Chromosomal and plasmid-encoded factors of Shigella flexneri induce secretogenic activity ex vivo.

PLoS One 2012 16;7(11):e49980. Epub 2012 Nov 16.

Department of Medicine, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0049980PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500342PMC
April 2013

Progress and pitfalls in Shigella vaccine research.

Nat Rev Gastroenterol Hepatol 2013 Apr 19;10(4):245-55. Epub 2013 Feb 19.

University of Maryland School of Medicine, Center for Vaccine Development, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2013.12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747556PMC
April 2013

Shigella flexneri effectors OspE1 and OspE2 mediate induced adherence to the colonic epithelium following bile salts exposure.

Mol Microbiol 2012 Jul 23;85(1):107-21. Epub 2012 May 23.

Department of Medicine, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2958.2012.08092.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399131PMC
July 2012

Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit.

Infect Immun 2011 Dec 3;79(12):4912-22. Epub 2011 Oct 3.

University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/IAI.05814-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232646PMC
December 2011

Formulation and stabilization of Francisella tularensis live vaccine strain.

J Pharm Sci 2011 Aug 13;100(8):3076-3087. Epub 2011 Apr 13.

Aridis Pharmaceuticals, San Jose, California 95138. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jps.22563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356159PMC
August 2011

Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cells.

FEMS Immunol Med Microbiol 2011 Apr 2;61(3):332-9. Epub 2011 Feb 2.

Centro de Estudios Moleculares, Departamento de Pediatría, Hospital Luis Calvo Mackennna, Facultad de Medicina, Universidad de Chile, Santiago, Chile.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1574-695X.2011.00778.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055916PMC
April 2011

Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling.

J Leukoc Biol 2010 Feb 4;87(2):275-81. Epub 2009 Nov 4.

Department of Microbiology and Immunology, University of Maryland, Baltimore, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.0909619DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812562PMC
February 2010

Vaccines against tularemia.

Hum Vaccin 2009 Dec 11;5(12):832-8. Epub 2009 Dec 11.

University of Maryland School of Medicine, Center for Vaccine Development, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132883PMC
http://dx.doi.org/10.4161/hv.10297DOI Listing
December 2009

Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages.

Infect Immun 2007 Aug 21;75(8):4127-37. Epub 2007 May 21.

Department of Microbiology and Immunology, University of Maryland, Baltimore, 660 West Redwood Street, Room 324, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/IAI.01868-06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1951974PMC
August 2007

Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Nat Rev Microbiol 2007 Jul;5(7):540-53

Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrmicro1662DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771495PMC
July 2007

Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.

Vaccine 2006 May 22;24(18):3727-34. Epub 2005 Jul 22.

Center for Vaccine Development, University of Maryland, Baltimore, 685 West Baltimore Street, MD 21201, USA.

View Article

Download full-text PDF

Source
http://www.umventures.org/sites/umventures.com/files/attachm
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S0264410X0500664
Publisher Site
http://dx.doi.org/10.1016/j.vaccine.2005.07.013DOI Listing
May 2006

Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies.

J Immunol 2006 May;176(9):5671-81

Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.176.9.5671DOI Listing
May 2006

Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208.

J Infect Dis 2004 Nov 19;190(10):1745-54. Epub 2004 Oct 19.

Division of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/jid/article-lookup/doi/10.1086/4246
Publisher Site
http://dx.doi.org/10.1086/424680DOI Listing
November 2004

Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy.

Vaccine 2004 Sep;22(27-28):3744-50

Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2004.03.025DOI Listing
September 2004

Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains.

Vaccine 2003 Jan;21(5-6):333-40

Center for Vaccine Development, University of Maryland, 685 West Baltimore Street, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0264-410x(02)00611-4DOI Listing
January 2003

Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL.

Infect Immun 2002 Jul;70(7):3611-20

Unidad de Investigación Médica en Inmunología e Infectología, Hospital de Infectología Dr. Daniel Méndez Hernández, Centro Médico La Raza, Instituto Mexicano del Seguro Social, Mexico D.F., Mexico.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC128084PMC
http://dx.doi.org/10.1128/iai.70.7.3611-3620.2002DOI Listing
July 2002